Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.000
-0.170 (-5.36%)
At close: Apr 13, 2026, 4:00 PM EDT
3.000
0.00 (0.00%)
After-hours: Apr 13, 2026, 4:00 PM EDT

IMDX Revenue

In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth. Insight Molecular Diagnostics had revenue of $1.14M in the quarter ending December 31, 2025, a decrease of -23.35%.

Revenue (ttm)
$4.06M
Revenue Growth
+115.58%
P/S Ratio
25.15
Revenue / Employee
$69,914
Employees
58
Market Cap
96.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.06M2.17M115.58%
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
Castle Biosciences344.23M
Fulgent Genetics322.67M
MDxHealth107.88M
FONAR106.03M
Prenetics Global92.39M
Biodesix88.50M
Burning Rock Biotech77.14M
Revenue Rankings